---
company: Vital Farms, Inc.
ticker: VITL
form: 8-K
filed: 2026-11-03
accepted: 2026-11-03T13:08:22+00:00
accession: 0001193125-26-444348
source: https://www.sec.gov/Archives/edgar/data/1579733/000119312526444348/
---

# Vital Farms (VITL) Q3 2026 earnings

## Header

- Company: Vital Farms, Inc.
- Reported: 2026-11-03 08:08 BMO ET
- Source: 8-K only — accession 0001193125-26-444348, Item 2.02 + Exhibit 99.1
- Verdict: Sequential revenue and margin recovery, but full-year guidance cut and long-term targets withdrawn.

## Headline numbers

| Metric | Actual | YoY | QoQ | 8-K location |
|---|---|---|---|---|
| Revenue | $182.2M | -8.4% | +9.7% | Ex. 99.1 |
| EPS (GAAP) | $-0.15 | $-0.51 | $+0.57 | Ex. 99.1 |

## Revenue breakdown

not stated in the 8-K

## Margins and costs

- Gross margin: 23.1% (prior 37.7%, change +16.5 pp)
- Operating expenses: $49.8M (+4.8% YoY)
- One-offs in the quarter: Restructuring and severance costs: $3.3M; Costs related to exit of butter products: $7.8M
- Effective tax rate: 30.1% (prior-year 25.3%, year-to-date 24.8%)
- Non-GAAP bridge: Adds back Depreciation and amortization ($4.3M), Stock-based compensation ($3.1M), Amortization of cloud computing arrangements ($0.7M), Restructuring and severance costs ($3.3M), and Costs related to exit of butter products ($7.8M).

## KPIs

| Metric | Actual | Prior quarter | Prior year | Change |
|---|---:|---:|---:|---|
| Cash and cash equivalents | $84.0M | $21.2M | $227K | +$62.8M |
| Outstanding debt | $117.6M | $30.0M | $0 | +$87.6M |
| Capital expenditures | $51.7M | $37.5M | $10.0M | +$41.7M |

## Guidance

| Metric | Guide | Prior guide | Change |
|---|---|---:|---|
| Net revenue | around $730M | $775M to $800M | -$45M to -$70M |
| Adjusted EBITDA | around $(15)M | $0 to $10M | -$15M to -$25M |
| Capital expenditures | $70M to $75M | $70M to $75M | No change |

## What drove it

- Revenue story: Revenue decreased 8.4% YoY to $182.2M, driven by price/mix and volume declines, but improved sequentially by 9.7% from Q2.
- EPS story: Net loss per share narrowed to $0.15 from $0.72 in Q2, driven by higher gross margin and lower SG&A.
- One-off check: Restructuring and severance costs of $3.3M and exit costs of $7.8M related to butter products.

## The good

- Gross margin improved 16.5 pp sequentially to 23.1%
- Adjusted EBITDA turned positive sequentially at $1.5M
- Cash balance increased to $84.0M

## The bad

- Net revenue down 8.4% YoY
- Full-year revenue outlook cut by $45M to $70M
- Adjusted EBITDA outlook cut to a loss of $15M

## The ugly

- Withdrawal of Fiscal 2030 financial targets

## Open questions

- Impact of later-than-anticipated distribution placements on near-term velocity
- Assumption of no seasonal uplift in demand or conventional egg pricing

## Full release

### Vital Farms (VITL) earnings release, November 3, 2026

Vital Farms, Inc. (VITL) · Form 8-K, Item 2.02 · Filed 2026-11-03 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1579733/000119312526444348/)

Vital Farms Reports Third Quarter 2026 Financial Results

Third Quarter Net Revenue of $182.2 Million, Up 9.7% Sequentially from the Second Quarter

Reaches Record Dollar and Volume Share of the Shell Egg Category

Updates Fiscal Year 2026 Net Revenue Outlook to around $730 Million and Adjusted EBITDA Outlook to a Loss of around $(15) Million

Withdraws Previously Issued Fiscal 2030 Financial Targets

Reaffirms Fiscal Year Capital Expenditure Outlook of $70 Million to $75 Million

AUSTIN, TX – November 3, 2026 – Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today reported financial results for its third quarter ended September 27, 2026.

Financial highlights for the third quarter ended September 27, 2026, compared to the third quarter ended September 28, 2025, where applicable, include:

• Net Revenue of $182.2 million, a decrease of 8.4% year over year and an increase of 9.7% sequentially from the second quarter of fiscal 2026

• Gross Margin of 23.1%, compared to 37.7%

• Net Loss of $6.5 million, compared to Net Income of $16.4 million

• Net Loss per Diluted Share of $0.15, compared to Net Income per Diluted Share of $0.36

• Adjusted EBITDA of $1.5 million, compared to $27.4 million in the prior-year quarter but improved $28.1 million sequentially from the second quarter of fiscal 2026¹

“Q3 represented a meaningful sequential improvement from Q2, consistent with our previously communicated expectation that Q2 would represent the trough in our financial performance. Net revenue and Adjusted EBITDA both improved sequentially, distribution expanded, we reached record dollar and volume share of the shell egg category, and we made progress reducing excess supply and lowering our cost structure,” said Russell Diez-Canseco, Vital Farms’ Executive Chairperson, President and CEO.

“At the same time, our performance this year has given us a clearer understanding of the factors affecting our growth as the egg category has normalized following several years of disruption from avian influenza. We achieved the distribution gains we expected, although some of that distribution came on shelf later than planned, and we are taking a more conservative view of its near-term velocity contribution. We are focused on building velocity across our expanded distribution base, adding distribution where it makes sense, bringing new households to the Vital Farms brand, and maintaining discipline across supply and costs. We remain confident in Vital Farms’ long-term opportunity, and we are focused on demonstrating sustained progress through more consistent growth and improved profitability over time.”¹

Adjusted EBITDA is a non-GAAP financial measure defined in the section titled “Non-GAAP Financial Measures” below and is reconciled to net (loss) income, its closest comparable GAAP measure, at the end of this release.

For the 13 Weeks Ended September 27, 2026

Net revenue decreased 8.4% to $182.2 million in the third quarter of 2026, compared to $198.9 million in the third quarter of 2025. The decrease compared to the prior-year period was primarily driven by a price/mix decline of $14.3 million and a volume-driven decline of $2.2 million, excluding breaker and wholesale channel sales. Sales to breaker and wholesale channels contributed $0.3 million to the net revenue decline, as a large volume increase was almost entirely offset by a price decline. Net revenue from sales through our retail channel was $175.1 million and $189.7 million for the 13-week periods ended September 27, 2026 and September 28, 2025, respectively.

Gross profit was $42.1 million, or 23.1% of net revenue, in the third quarter of 2026, compared to $75.0 million, or 37.7% of net revenue, in the third quarter of 2025. Gross profit and margin decreases reflected higher input and production costs and unfavorable sales mix. The unfavorable sales mix was driven by an oversupply of egg inventory, which resulted in increased sales to breaker and wholesale channels at lower prices, reducing gross profit by $7.9 million.

Loss from operations was $7.7 million in the third quarter of 2026, compared to income from operations of $21.4 million in the third quarter of 2025. The decrease was driven primarily by higher input and production costs and unfavorable sales mix, partially offset by tighter spending controls.

Net loss was $6.5 million in the third quarter of 2026, compared to net income of $16.4 million in the prior-year quarter. The decrease primarily reflected lower gross profit and higher interest expense, partially offset by lower SG&A expenses and an income tax benefit.

Net loss per diluted share was $0.15 for the third quarter of 2026, compared to net income per diluted share of $0.36 in the prior-year quarter.

Adjusted EBITDA was $1.5 million in the third quarter of 2026, compared to Adjusted EBITDA of $27.4 million in the third quarter of 2025. The decrease was driven primarily by higher input and production expenses and unfavorable sales mix.

Adjusted EBITDA excludes certain non-cash and other items. Adjusted EBITDA is a non-GAAP financial measure defined in the section titled “Non-GAAP Financial Measures” below and is reconciled to net (loss) income, its closest comparable GAAP measure, at the end of this release.

Balance Sheet and Cash Flow Highlights

Cash and cash equivalents were $84.0 million as of September 27, 2026, and we had $117.6 million of outstanding debt. Net cash used in operating activities was $54.4 million for the 39-week period ended September 27, 2026, compared to net cash provided by operating activities of $27.9 million for the 39-week period ended September 28, 2025.

Capital expenditures totaled $51.7 million in the 39-week period ended September 27, 2026, compared to $44.0 million in the 39-week period ended September 28, 2025.

Fiscal 2026 Outlook... (truncated)orted by lower anticipated breaker and supply-management costs, the benefit of recent distribution gains and structural cost actions we have taken across the business,” said Thilo Wrede, Vital Farms’ Chief Financial Officer. “Our updated full-year outlook reflects the later-than-anticipated timing of certain new distribution placements, a more conservative assumption for their near-term velocity contribution, and no assumed seasonal uplift in demand or conventional egg pricing.”

For fiscal year 2026, we expect:

• Net revenue of around $730 million, compared to prior outlook of $775 million to $800 million.

• Adjusted EBITDA loss of around $(15) million, compared to prior outlook of a gain between $0 and $10 million.

• Capital expenditures in the range of $70 million to $75 million, reaffirmed from our prior outlook.

Vital Farms’ guidance assumes that there are no further material disruptions to the supply chain or its customers or consumers, including any material changes to the current macroeconomic environment. Vital Farms cannot provide a reconciliation between its forecasted Adjusted EBITDA and net (loss) income, its most directly comparable GAAP measure, without unreasonable effort due to the unavailability of reliable estimates for income taxes and stock-based compensation, among other items. These items are not within our control and may vary greatly between periods and could significantly impact future financial results.

Long-Term Targets

As Vital Farms continues to execute its near-term commercial and operational priorities, the Company is withdrawing its previously announced long-term targets for fiscal 2030. The Company expects to revisit long-term targets once it has made more progress expanding margins and improving profitability. The Company remains confident in its long-term opportunity. In the near term, Vital Farms is focused on executing its commercial and operational priorities, demonstrating sustained improvement in financial performance and maintaining discipline in how it allocates resources.

Conference Call and Webcast Details

Vital Farms will host a conference call and webcast at 8:30 a.m. ET today to discuss the results. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique PIN. Alternatively, participants may access the live webcast on the Vital Farms Investor Relations website at https://investors.vitalfarms.com under “Events & Presentations.” The webcast will be archived for 30 days.

In addition, Vital Farms will publish its November 2026 Corporate Presentation as supporting materials to the webcast on the Vital Farms Investor Relations website at https://investors.vitalfarms.com under “Events & Presentations.”

About Vital Farms

Vital Farms (Nasdaq: VITL) is a Certified B Corporation that offers a range of ethically produced foods nationwide. Started on a single farm in Austin, Texas, in 2007, Vital Farms is now a national consumer brand that works with more than 600 small farms and is the leading U.S. brand of pasture-raised eggs by retail dollar sales. Vital Farms’ ethics are exemplified by its focus on the humane treatment of farm animals and sustainable farming practices. In addition, as a Delaware public benefit corporation, Vital Farms prioritizes the long-term benefits of each of its stakeholders, including farmers and suppliers, customers and consumers, communities and the environment, and crew members and stockholders. Vital Farms’ products, including shell eggs, hard-boiled eggs, and liquid whole eggs, are sold in more than 24,500 stores nationwide. Vital Farms pasture-raised eggs can also be found on menus at hundreds of foodservice operators across the country. For more information, visit https://vitalfarms.com/.

Forward-Looking Statements

This press release and the earnings call referencing this press release contain “forward-looking” statements, as that term is defined under the federal securities laws, including but not limited to statements regarding Vital Farms’ long-term opportunity, business strategy and commercial and operational priorities, the impact and expected benefits of changes in Vital Farms’ cost structure and capital expenditures, and Vital Farms’ future financial performance, including management’s outlook for fiscal year 2026. These forward-looking statements are based on Vital Farms’ current assumptions, expectations, and beliefs and are subject to substantial risks, uncertainties, assumptions, and changes in circumstances that may cause Vital Farms’ actual results, performance, or achievements to differ materially from those expressed or implied in any forward-looking statement.

The risks and uncertainties referred to above include, but are not limited to: Vital Farms’ expectations regarding its revenue, expenses, and other operating results; Vital Farms’ ability to attract new consumers... (truncated)ts farmers, pullet vendors, suppliers, co-manufacturers, distributors, retailers, and foodservice customers, as well as the health of the foodservice industry generally; the effects of outbreaks of agricultural diseases, including avian influenza and egg drop syndrome, the perception that outbreaks may occur or regulatory or market responses to such outbreaks generally; the ability of Vital Farms, its farmers, pullet vendors, suppliers, and its co-manufacturers to comply with its standards and food safety, environmental or other laws or regulations; the potential outcome and impact of pending or future litigation, and the costs, expenses, and uncertainties associated therewith; specifications and timing of the expansion of Vital Farms’ processing capacity, and the impacts of prior or future expansions of such facilities on Vital Farms’ future revenue and farm network; future investments in its business, anticipated capital expenditures and estimates regarding capital requirements; anticipated changes in Vital Farms’ product offerings, including specifications, timing and financial impacts of the planned discontinuation of its butter products, and Vital Farms’ ability to innovate to offer new products or enter into new product categories; the costs and success of marketing efforts and ability to promote its brand; Vital Farms’ reliance on key personnel and its ability to identify, recruit and retain personnel; Vital Farms’ ability to effectively manage its growth; the potential influence of Vital Farms’ focus on a specific public benefit purpose and producing a positive effect for society; Vital Farms’ stated impact goals, opportunities and initiatives, as well as the standards and expectations of third parties regarding these matters; Vital Farms’ ability to maintain effective internal controls over financial reporting and to remediate and prevent material weaknesses in its internal controls; Vital Farms’ ability to compete effectively with existing competitors and new market entrants; the impact of adverse economic conditions, including as a result of unfavorable global economic and political conditions, elevated interest rates, and inflation; Vital Farms’ estimates of future capital expenditures and the sufficiency of Vital Farms’ cash, cash equivalents, any marketable securities and availability of credit under its credit facilities to meet liquidity needs; seasonality; and the growth rates of the markets in which Vital Farms competes.

These risks and uncertainties are more fully described in Vital Farms’ filings with the Securities and Exchange Commission (SEC), including in the sections entitled “Risk Factors” in its Quarterly Report on Form 10-Q for the fiscal quarter ended September 27, 2026, which Vital Farms anticipates filing on November 3, 2026, and other filings and reports that Vital Farms may file from time to time with the SEC. Moreover, Vital Farms operates in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for management to predict all risks, nor can Vital Farms assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements Vital Farms may make. In light of these risks, uncertainties, and assumptions, Vital Farms cannot guarantee future results, levels of activity, performance, achievements, or events and circumstances reflected in the forward-looking statements will occur. Forward-looking statements represent management’s beliefs and assumptions only as of the date of this press release. Vital Farms disclaims any obligation to update forward-looking statements except as required by law.

#### Financial statements

##### Income Statement (13-Weeks Ended — (Unaudited) (in thousands))

| | 13-Weeks Ended – September 27, 2026 | 13-Weeks Ended – September 28, 2025 | 39-Weeks Ended – September 27, 2026 | 39-Weeks Ended – September 28, 2025 |
|---|---:|---:|---:|---:|
| Net revenue | 182,164 | 198,936 | 535,348 | 545,892 |
| Cost of goods sold | 140,024 | 123,974 | 429,268 | 336,635 |
| Gross profit | 42,140 | 74,962 | 106,080 | 209,257 |
| **Operating expenses:** | | | | |
| Selling, general and administrative | 38,136 | 44,394 | 122,876 | 115,290 |
| Shipping and distribution | 11,685 | 9,169 | 33,364 | 27,004 |
| Total operating expenses | 49,821 | 53,563 | 156,240 | 142,294 |
| (Loss) income from operations | -7,681 | 21,399 | -50,160 | 66,963 |
| **Other income (expense), net:** | | | | |
| Interest expense | -2,930 | -213 | -3,541 | -666 |
| Interest income | 330 | 1,270 | 1,330 | 3,814 |
| Other income (expense), net | 1,046 | -487 | 487 | -1,268 |
| Total other (expense) income, net | -1,554 | 570 | -1,724 | 1,880 |
| Net (loss) income before income taxes | -9,235 | 21,969 | -51,884 | 68,843 |
| Income tax (benefit) provision | -2,775 | 5,550 | -12,837 | 18,885 |
| Net (loss) income | -6,460 | 16,419 | -39,047 | 49,958 |
| **Net (loss) income per share:** | | | | |
| Basic: | -0.15 | 0.37 | -0.91 | 1.12 |
| Diluted: | -0.15 | 0.36 | -0.91 | 1.09 |
| **Weighted average common shares outstanding:** | | | | |
| Basic: | 42,931,849 | 44,721,206 | 42,730,366 | 44,521,146 |
| Diluted: | 42,931,849 | 46,205,737 | 42,730,366 | 45,965,987 |

##### Income Statement (13-Weeks Ended — (Unaudited) (in thousands))

| | 13-Weeks Ended – September 27, 2026 | 13-Weeks Ended – September 28, 2025 | 39-Weeks Ended – September 27, 2026 | 39-Weeks Ended – September 28, 2025 |
|---|---:|---:|---:|---:|
| Net (loss) income | -6,460 | 16,419 | -39,047 | 49,958 |
| Depreciation and amortization1 | 4,317 | 3,236 | 11,914 | 9,963 |
| Stock-based compensation (benefit) expense | 3,122 | 3,239 | 4,500 | 9,126 |
| Income tax (benefit) provision | -2,775 | 5,550 | -12,837 | 18,885 |
| Interest expense | 2,930 | 213 | 3,541 | 666 |
| Interest income | -330 | -1,270 | -1,330 | -3,814 |
| Amortization of cloud computing arrangements | 693 |  | 2,090 |  |
| Restructuring and severance costs |  |  | 3,312 |  |
| Costs related to our exit of butter products |  |  | 7,764 |  |
| Adjusted EBITDA | 1,497 | 27,387 | -20,093 | 84,784 |
| Net revenue | 182,164 | 198,936 | 535,348 | 545,892 |
| Net (loss) income margin2 | -3.5% | 8.3 | -7.3% | 9.2 |
| Adjusted EBITDA margin3 | 0.8% | 13.8 | -3.8% | 15.5 |

##### Balance Sheet (September 27, 2026 — (Unaudited) (in thousands))

| | September 27, 2026 – (Unaudited) | December 28, 2025 |
|---|---:|---:|
| **Current assets:** | | |
| Cash and cash equivalents | 83,952 | 48,831 |
| Investment securities, available-for-sale |  | 64,520 |
| Accounts receivable, net of allowance for credit losses of $1,419 and $685 as of September 27, 2026 and December 28, 2025, respectively | 60,615 | 67,849 |
| Inventories | 50,253 | 66,495 |
| Prepaid expenses and other current assets, net of allowance for credit losses of $84 and $34 as of September 27, 2026 and December 28, 2025, respectively | 15,347 | 11,304 |
| Income taxes receivable | 1,725 | 1,410 |
| Assets held for sale | 2,141 | 2,141 |
| Total current assets | 214,033 | 262,550 |
| Property, plant and equipment, net | 195,676 | 160,601 |
| Operating lease right-of-use assets | 132,617 | 80,390 |
| Goodwill and other assets | 27,825 | 15,197 |
| Total assets | 570,151 | 518,738 |
| **Current liabilities:** | | |
| Accounts payable | 47,972 | 55,141 |
| Accrued liabilities | 52,339 | 54,826 |
| Operating lease liabilities, current | 29,320 | 4,673 |
| Finance lease liabilities, current | 6,005 | 5,670 |
| Current portion of long-term debt | 1,250 |  |
| Income taxes payable | 44 | 1,268 |
| Total current liabilities | 136,930 | 121,578 |
| Long-term debt, less current portion | 116,385 |  |
| Operating lease liabilities, non-current | 35,457 | 38,050 |
| Finance lease liabilities, non-current | 556 | 5,098 |
| Other liabilities | 512 | 2,752 |
| Total liabilities | 289,840 | 167,478 |
| **Stockholders’ equity:** | | |
| Common stock, $0.0001 par value per share, 310,000,000 shares authorized as of September 27, 2026 and December 28, 2025; 42,935,200 and 44,797,125 shares issued and outstanding as of September 27, 2026 and December 28, 2025, respectively | 4 | 4 |
| Additional paid-in capital | 169,951 | 201,820 |
| Retained earnings | 110,348 | 149,395 |
| Accumulated other comprehensive income | 8 | 41 |
| Total stockholders’ equity | 280,311 | 351,260 |
| Total liabilities and stockholders’ equity | 570,151 | 518,738 |

##### Cash Flow (39-Weeks Ended — (Unaudited) (in thousands))

| | 39-Weeks Ended – September 27, 2026 | 39-Weeks Ended – September 28, 2025 |
|---|---:|---:|
| **Cash flows from operating activities:** | | |
| Net (loss) income | -39,047 | 49,958 |
| **Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:** | | |
| Depreciation and amortization | 11,914 | 9,963 |
| Reduction in the carrying amount of right-of-use assets | 13,483 | 6,018 |
| Stock-based compensation expense | 4,500 | 9,126 |
